相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions
Mark A. Eckert et al.
JOURNAL OF CELL SCIENCE (2017)
A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression
Simon Grelet et al.
NATURE CELL BIOLOGY (2017)
Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy
Eunji Jang et al.
BIOMATERIALS (2016)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas
Junwen Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma
R. Dong et al.
CELL DEATH & DISEASE (2016)
A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division
Lihua Wang et al.
ELIFE (2016)
The emerging role of IncRNAs in cancer
Maite Huarte
NATURE MEDICINE (2015)
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Matjaz Rokavec et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The multilayered complexity of ceRNA crosstalk and competition
Yvonne Tay et al.
NATURE (2014)
被撤回的出版物: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Retracted article. See vol. 582, pg. 134, 2020)
Jing Y. Krzeszinski et al.
NATURE (2014)
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
Pedro J. Batista et al.
CELL (2013)
MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1
Laisheng Li et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2013)
The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs
Amanda N. Kallen et al.
MOLECULAR CELL (2013)
First microRNA mimic enters clinic
Aaron Bouchie
NATURE BIOTECHNOLOGY (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
Pengyuan Yang et al.
CANCER CELL (2012)
Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion
Laisheng Li et al.
MOLECULAR THERAPY (2012)
A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion
V. H. Rao et al.
ONCOGENE (2012)
Intact p53-Dependent Responses in miR-34-Deficient Mice
Carla P. Concepcion et al.
PLOS GENETICS (2012)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Andrea L. Kasinski et al.
NATURE REVIEWS CANCER (2011)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
Role of ADAMS in Cancer Formation and Progression
Michael J. Duffy et al.
CLINICAL CANCER RESEARCH (2009)
CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine
Lei Kong et al.
NUCLEIC ACIDS RESEARCH (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Molecular profiling of ADAM12 in human bladder cancer
Camilla Frohlich et al.
CLINICAL CANCER RESEARCH (2006)
ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage
R Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ADAM12 in human liver cancers:: TGF-β-regulated expression in stellate cells is associated with matrix remodeling
H Le Pabic et al.
HEPATOLOGY (2003)
分享论文
